Benjamín Nogueda-Torres

13PUBLICATIONS
34CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsTe mātauranga kura tuarua Māori (Māori secondary education)Traditional Chinese medicine and treatmentsPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 14, 2026
An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.

Rogelio Gómez-Escobedo, Domingo Méndez-Álvarez, Alma D Paz-González

|Feb 26, 2026
Identification of Novel <i>Trypanosoma cruzi</i> Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity.

Lenci K Vázquez-Jiménez, Alonzo González-González, Timoteo Delgado-Maldonado

|Sep 26, 2025
Phytochemical Analysis and Appraisal of Antiproliferative Activity of <i>Magnolia alejandrae</i>.

José E Caballero-Chávez, Alma D Paz-González, Diana V Navarrete-Carriola

|Jun 27, 2025
In Silico Investigation of TATA-Binding Protein as a Therapeutic Target for Chagas Disease: Insights into FDA Drug Repositioning.

Carlos Gaona-López, Domingo Méndez-Álvarez, Alonzo Gonzalez-Gonzalez

|Feb 26, 2025
Exploring Marine Natural Compounds: Innovative Therapeutic Candidates Against Chagas Disease Through Virtual Screening and Molecular Dynamics.

Carlos Eliel Maya-Ramírez, Asmae Saih, Alfonso Méndez Tenorio

|Jan 25, 2025
Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for <i>Trypanosoma cruzi</i> Infection.

Citlali Vázquez, Rusely Encalada, Isabel Jiménez-Galicia

Pageof 3